# South Korea Structural Heart Devices Market > South Korea Structural Heart Devices Market Research Report: Size, Share, Trend Analysis By Types (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures)– Competitor Industry Analysis and Trends Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.38% - **2024:** $ 19.25 Million - **2025:** $ 20.67 Million - **2035:** $ 42.15 Million - **Key Players:** Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), LivaNova (GB), Cardiac Dimensions (US), AtriCure (US), Terumo Corporation (JP), JenaValve Technology (DE) **Report ID:** MRFR/MED/55135-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-structural-heart-devices-market-56901 --- ## Market Summary ## **South Korea Structural Heart Devices Market Overview** As per MRFR analysis, the South Korea Structural Heart Devices Market Size was estimated at 17.75 (USD Million) in 2024.The South Korea Structural Heart Devices Market Industry is expected to grow from 19.25(USD Million) in 2025 to 45.6 (USD Million) by 2035. The South Korea Structural Heart Devices Market CAGR (growth rate) is expected to be around 8.155% during the forecast period (2025 - 2035). ### **Key South Korea Structural Heart Devices Market Trends Highlighted** The South Korea Structural Heart Devices Market is currently experiencing significant trends driven by an increase in cardiovascular diseases and a growing aging population. The government of South Korea has prioritized healthcare improvements, leading to heightened awareness about heart diseases, which is prompting more patients to seek treatment.  This rise in patient numbers is a key market driver, motivating healthcare providers to invest in advanced technologies and innovations in structural heart devices. With a strong emphasis on improving healthcare infrastructure, South Korea is enhancing its hospital systems which, in turn, supports the availability and adoption of these medical devices. In recent times, there has been a notable shift toward minimally invasive procedures. Many South Korean hospitals are adopting techniques that reduce recovery time and associated risks, which is appealing to patients and healthcare professionals alike.  This trend toward less invasive surgical approaches is also fostered by education and training initiatives aimed at upskilling medical personnel in novel techniques and technologies. Additionally, collaborations between local companies and international firms are creating opportunities for product development and market expansion within this segment.  There is also an opportunity for the market to explore advancements in digital healthcare and telemedicine, especially in the context of post-operative care and remote patient monitoring. The integration of artificial intelligence and machine learning in device functionality presents a chance to enhance patient outcomes and streamline processes. As healthcare policies evolve and investment in health technology increases, there is a promising landscape for the growth and diversification of structural heart devices in South Korea, making it essential for stakeholders to stay attuned to these trends. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South Korea Structural Heart Devices Market Drivers** ### **Aging Population Driving Demand for Structural Heart Devices** The aging population in South Korea is a significant driver for the South Korea [Structural Heart Devices Market](../../../reports/structural-heart-devices-market-6385) Industry. According to the Korean Statistical Information Service, the proportion of individuals aged 65 and older is projected to reach 24.3% by 2030, up from 18.9% in 2020. This rising demographic segment typically exhibits a higher incidence of cardiovascular diseases, which necessitate advanced treatment options such as structural heart devices. Major healthcare organizations, including the Korea National Health Insurance Service, are reporting increased healthcare spending focused on cardiovascular health. As a result, there has been a consistent demand for innovative solutions to manage heart diseases, paving the way for the growth of the structural heart devices market.  This trend is expected to persist as healthcare systems adapt to cater to the specific needs of an aging population, fostering innovation and investment in the structural heart device sector. ### **Technological Advancements in Surgical Techniques** Recent advancements in minimally invasive surgical techniques are propelling the growth of the South Korea Structural Heart Devices Market Industry. The introduction of cutting-edge procedures, such as transcatheter aortic valve replacement (TAVR) and left atrial appendage closure, has expanded the treatment landscape for patients with structural heart conditions.  According to the Ministry of Health and Welfare in South Korea, the adoption of these advanced techniques has led to a 15% increase in successful surgical outcomes among older patients.Established companies such as Abbott Laboratories and Boston Scientific are at the forefront of this innovation, developing devices that enhance patient safety and recovery.  As these technological advancements continue to emerge, they significantly contribute to market growth by increasing the acceptance of these procedures among healthcare professionals and patients alike. ### **Government Initiatives and Funding for Cardiac Care** The South Korean government has the importance of cardiovascular health and is implementing initiatives aimed at enhancing cardiac care, which directly benefits the South Korea Structural Heart Devices Market Industry. The Health Insurance Review and Assessment Service has launched programs that allocate increased funding for advanced cardiac procedures and devices. In 2022, the government invested approximately 20 million USD into research grants aimed at developing new structural heart interventions. These initiatives help incorporate new devices and technologies into the healthcare system, which makes it easier for patients to access health services. This support from the government not only enhances local production but also stimulates international partnerships, attracting more important healthcare industry attention and investment into the market. ### **Increase in Awareness and Screening for Cardiovascular Health** Growing awareness about cardiovascular health and an increase in screening initiatives are significantly bolstering the South Korea Structural Heart Devices Market Industry. The Korean Cardiac Society reports that public health campaigns have led to a 30% increase in regular cardiac screening among adults aged 40 and over. This heightened awareness has resulted in earlier diagnoses of structural heart conditions, creating a growing need for treatment solutions. Prominent healthcare organizations like the Korean Society of Cardiology are actively promoting education regarding heart health, further facilitating early intervention. This trend is catalyzing demand for structural heart devices as patients become more informed about their health and healthcare providers are equipped to provide necessary treatment options in a timely manner. ## **South Korea Structural Heart Devices Market Segment Insights****:** ### **Structural Heart Devices Market Type Insights** The South Korea Structural Heart Devices Market has shown a notable growth trajectory, with Type-based segmentation revealing key insights into its components, including Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems. Heart Valve Devices represent a critical sector within this market, vital for treating various valvular heart diseases.   the aging population in South Korea and the rising prevalence of heart-related conditions, there is an increasing demand for innovative and effective heart valve replacement technologies.Similarly, Annuloplasty Rings play an essential role in the treatment of heart valve malfunctions, offering stability and durability during surgical procedures, thus contributing to improved patient outcomes. Occluders, which are pivotal in treating structural heart defects such as atrial septal defects, are also gaining traction.  Their significance stems from their minimally invasive nature, leading to shorter recovery times and reducing the overall healthcare burden. Delivery Systems are crucial as they facilitate the implantation of structural heart devices effectively and safely.The advancements in technology related to these systems enhance procedural efficiency and patient safety.  Overall, the segmentation in the South Korea Structural Heart Devices Market underscores the sophisticated landscape of heart care, shaped by emerging technologies and a growing need for effective interventions in the face of rising cardiovascular diseases in the region.  As a result, each component plays a significant and interrelated role in enhancing the standard of heart care in South Korea, affirming the importance of continued innovation to meet the evolving health needs of its population. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Structural Heart Devices Market Indication Insights** The South Korea Structural Heart Devices Market showcases a distinct segmentation based on Indication, prominently featuring Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease is significant within the South Korean healthcare landscape due to the rising prevalence of age-related conditions, leading to increased healthcare demand for innovative solutions.  Similarly, Cardiomyopathy, affecting the heart muscle's ability to pump blood, requires specialized structural devices to enhance patient care.  The growing aging population in South Korea, coupled with advancements in technology and surgical techniques, is further propelling the demand for these particular indications in structural heart interventions.As healthcare providers strive towards improved outcomes and quality of life for patients, these segments are poised to play a critical role in shaping the future of cardiac care in the region.  With the emphasis on expanding treatment options and expanding accessibility, stakeholders are increasingly investing in Research and Development initiatives for these indications, ensuring a robust growth trajectory for the market. ### **Structural Heart Devices Market Procedure Insights** The South Korea Structural Heart Devices Market, focusing on the Procedure segment, showcases significant growth driven by advancements in medical technology and an aging population. Replacement Procedures, which involve the substitution of damaged heart structures, often dominate this segment due to their critical nature in treating severe cardiovascular conditions.  This aspect is further bolstered by increasing cardiovascular disease prevalence in South Korea, prompting a need for innovative solutions.  On the other hand, Repair Procedures aimed at fixing existing heart structures play a crucial role in addressing less severe but still problematic heart anomalies.Their significance lies in the ability to minimize patient recovery time and associated costs. As healthcare infrastructure in South Korea continues to evolve and more clinicians adopt advanced techniques, a considerable portion of the South Korea Structural Heart Devices Market will likely be driven by both Replacement and Repair Procedures, focusing on improving patient outcomes and reducing the burden of heart diseases.  The combination of demographic trends and technological improvements poised to enhance the overall efficacy of procedures in this market, reflecting wider market trends and aligning with global best practices in cardiac care. ## **South Korea Structural Heart Devices Market Key Players and Competitive Insights****:** The South Korea Structural Heart Devices Market is a rapidly evolving sector within the medical devices industry, characterized by significant advancements and competitive dynamics. As the prevalence of cardiovascular diseases continues to rise, the demand for structural heart interventions has surged, leading to increased innovation and investment in this market.  The competitive landscape is shaped by a mix of established players and emerging companies that are focusing on developing novel therapies and devices to address a range of structural heart conditions.  The market is marked by continuous advancements in technology, regulatory changes, and evolving patient needs, compelling companies to constantly adapt their strategies to maintain a competitive edge.Transcatheter Technologies has solidified its presence in the South Korea Structural Heart Devices Market through its commitment to providing innovative transcatheter solutions for cardiac conditions. The company's strengths lie in its advanced technology, which aims to enhance procedural efficiencies and improve patient outcomes.  Their emphasis on research and development has led to a robust portfolio that addresses various structural heart issues through minimally invasive approaches. With a strong focus on clinical efficacy and patient safety, Transcatheter Technologies has developed a reputation for delivering high-quality devices. The company’s strategic collaborations with healthcare institutions and continued engagement in clinical trials further augment its competitive position within the South Korean market, underscoring its commitment to pioneering advancements in heart health. Medtronic stands as a formidable player in the South Korea Structural Heart Devices Market, leveraging its extensive experience and market reach. Known for its comprehensive range of products, Medtronic offers various structural heart devices designed to treat conditions such as valvular heart diseases and congenital heart defects.  The company benefits from strong brand recognition, which has been built through continuous innovation and strategic mergers and acquisitions aimed at enhancing its product offerings. Medtronic's key product line includes transcatheter heart valves and devices that facilitate minimally invasive procedures, thus significantly improving surgical outcomes. Its proactive approach to engaging with healthcare professionals and participating in regional medical conferences strengthens its market presence and fosters strategic partnerships.  This enables Medtronic to stay at the forefront of the industry, continuously addressing the evolving needs of the South Korean population while maintaining a focus on enhancing patient care through technologically advanced solutions. ### **Key Companies in the South Korea Structural Heart Devices Market Include:** - Transcatheter Technologies - [Medtronic](https://www.medtronic.com/in-en/healthcare-professionals/education-training/medical-education/therapies/structural-heart.html) - Corindus Vascular Robotics - Abbott Laboratories - Cardiac Dimensions - Nuvem - Boston Scientific - Cameron Health - Fumedica - Aortica Corporation - SentreHEART - Edwards Lifesciences - CryoLife - Vascular Dynamics - LivaNova ## **South Korea Structural Heart Devices Market Industry Developments** In recent months, the South Korea Structural Heart Devices Market has seen significant advancements, with major players like Medtronic, Abbott Laboratories, and Edwards Lifesciences actively expanding their portfolios to meet growing demand. Medtronic launched its latest transcatheter aortic valve replacement technology in March 2023, aimed at improving surgical outcomes.  Meanwhile, Abbott Laboratories introduced new features in their heart monitoring systems, enhancing patient care. In terms of mergers and acquisitions, Corindus Vascular Robotics completed an acquisition by Siemens Healthineers in September 2022, strengthening their market position.  The growing prevalence of heart diseases in South Korea has spurred investment in innovative solutions, leading to an estimated market valuation growth of 8.5% in the past year alone, contributing to enhanced treatment options for patients. Various companies, including Boston Scientific and CryoLife, have also invested in local Research and Development initiatives to adapt to South Korean healthcare regulations.  The consistent emphasis on quality and regulatory compliance by the South Korean government is paving the way for advanced structural heart devices, thereby influencing market dynamics and encouraging technological collaborations among leading organizations in the sector. ## **South Korea Structural Heart Devices Market Segmentation Insights** ### **Structural Heart Devices Market Type****Outlook** - Heart Valve Devices - Annuloplasty Rings - Occluders - Delivery Systems ### **Structural Heart Devices Market Indication****Outlook** - Valvular Heart Disease - Cardiomyopathy ### **Structural Heart Devices Market Procedure****Outlook** - Replacement Procedures - Repair Procedures ## Market Drivers ### Advancements in Imaging Technologies The evolution of imaging technologies plays a crucial role in the structural heart-devices market. Enhanced imaging modalities, such as 3D echocardiography and cardiac MRI, facilitate precise diagnosis and treatment planning for structural heart conditions. These advancements enable healthcare professionals to visualize complex anatomical structures, leading to improved procedural outcomes. As imaging technologies become more integrated into clinical practice, they are likely to drive the adoption of structural heart devices. The ability to accurately assess heart conditions allows for better patient selection and device placement, which is essential for successful interventions. Consequently, the structural heart-devices market may witness increased demand as healthcare facilities invest in state-of-the-art imaging solutions to complement their therapeutic offerings. ### Rising Awareness and Education Initiatives There is a growing awareness of heart health among the South Korean population, which is positively influencing the structural heart-devices market. Educational campaigns aimed at informing the public about cardiovascular diseases and available treatment options are becoming more prevalent. As individuals become more knowledgeable about their health, they are more likely to seek medical attention for heart-related issues. This increased awareness is driving demand for structural heart devices, as patients are more inclined to explore advanced treatment options. Healthcare providers are also focusing on educating their staff about the latest technologies, which may further enhance the adoption of these devices in clinical practice. The structural heart-devices market could see a notable uptick in demand as a result of these initiatives. ### Collaboration Between Industry and Academia Collaborative efforts between industry stakeholders and academic institutions are fostering innovation in the structural heart-devices market. Research partnerships are leading to the development of novel devices and techniques that address unmet clinical needs. These collaborations often result in clinical trials that validate the efficacy and safety of new products, thereby accelerating their entry into the market. As universities and research organizations work closely with manufacturers, the pace of innovation is likely to increase, providing healthcare professionals with more effective tools for treating structural heart conditions. This synergy may contribute to a robust growth trajectory for the structural heart-devices market, with potential advancements expected to emerge in the next few years. ### Growing Investment in Healthcare Infrastructure The South Korean government's commitment to enhancing healthcare infrastructure significantly impacts the structural heart-devices market. Increased funding for hospitals and medical facilities aims to improve access to advanced medical technologies. This investment is likely to facilitate the acquisition of cutting-edge structural heart devices, thereby expanding treatment options for patients. Furthermore, the establishment of specialized cardiac centers is expected to enhance the quality of care provided to individuals with heart conditions. As healthcare infrastructure continues to develop, the structural heart-devices market may experience accelerated growth, with projections indicating a potential increase in market size by 15% over the next five years. ### Increasing Prevalence of Cardiovascular Diseases The rising incidence of cardiovascular diseases in South Korea is a primary driver for the structural heart-devices market. According to health statistics, cardiovascular diseases account for a significant portion of mortality rates, prompting a growing need for effective treatment options. The demand for innovative devices that can address conditions such as heart valve disorders and congenital heart defects is escalating. This trend is further supported by an aging population, which is more susceptible to heart-related ailments. As healthcare providers seek to improve patient outcomes, investments in advanced structural heart devices are likely to increase. The structural heart-devices market is expected to expand as hospitals and clinics adopt these technologies to enhance their treatment capabilities, potentially leading to a market growth rate of over 10% annually in the coming years. ## Future Outlook The [Structural Heart Devices Market](https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385) in South Korea is projected to grow at a 7.38% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand. **New opportunities:** - Development of minimally invasive surgical techniques for heart valve repair. Expansion of telehealth services for remote patient monitoring. Investment in R&D for innovative biomaterials in device manufacturing. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic investments. ## Segment Insights ### By Type: Transcatheter Aortic Valve Replacement (Largest) vs. Mitral Valve Repair Devices (Fastest-Growing) In the South Korea structural heart-devices market, the distribution of market share among the various device types reveals that Transcatheter Aortic Valve Replacement (TAVR) commands the largest segment, attributed to its increasing adoption and favorable procedural outcomes. Following TAVR, Mitral Valve Repair Devices have been gaining traction, reflecting a shift in clinical preference towards valve preservation techniques. Growth trends indicate a robust expansion trajectory for Mitral Valve Repair Devices, with advancements in technology driving increased surgical options. The rising prevalence of mitral valve disorders and an aging population further fuel demand. TAVR still remains dominant due to its established efficacy and safety profile, yet Mitral Valve Repair Devices are emerging rapidly as procedural efficiency improves, potentially changing the dynamics in the market. Transcatheter Aortic Valve Replacement (Dominant) vs. Mitral Valve Repair Devices (Emerging) Transcatheter Aortic Valve Replacement (TAVR) is recognized as the dominant technology in the South Korea structural heart-devices market, primarily due to its minimally invasive nature and effective treatment for severe aortic stenosis. Patients benefit from quicker recovery times and lower procedural risks. On the other hand, Mitral Valve Repair Devices, while currently seen as emerging, are increasingly popular due to innovative device designs and enhanced procedural techniques that cater to a wider range of mitral valve disorders. This emerging trend signals a shift in market dynamics as clinical practices begin to favor repair over replacement, broadening access to innovative therapies and improving patient outcomes. ### By Procedure Type: Minimally Invasive (Largest) vs. Surgical (Fastest-Growing) In the South Korea structural heart-devices market, the distribution of market share among procedure types is distinctly led by Minimally Invasive techniques, which dominate the landscape due to their efficiency and lower recovery times. Surgical approaches hold a significant portion of the market, but they are challenged by the increasing preference for less invasive alternatives. Percutaneous methods are also gaining traction, contributing to the overall diversity of procedure offerings despite holding a smaller slice compared to the other two. Growth trends for the procedure type segment are promising, with Minimally Invasive techniques continuing their growth trajectory as advancements in technology enhance their effectiveness. The Surgical segment is projected to experience the fastest growth, driven by ongoing innovations and an increasing number of procedures. Expanding patient awareness and preference for quicker recovery options are major factors fueling this trend, with Percutaneous methods gradually emerging as feasible options for select patient populations. Minimally Invasive (Dominant) vs. Surgical (Emerging) The Minimally Invasive segment is characterized by its focus on reducing patient trauma and expediting recovery times, making it the dominant procedure type in the South Korea structural heart-devices market. This segment encompasses a range of techniques designed to minimize surgical impact, resulting in increased adoption among patients and healthcare providers alike. In contrast, the Surgical segment, while currently the fastest-growing, is redefining its practices through technological advancements. These include enhanced surgical tools and techniques that improve safety and outcomes. As these two segments evolve, their interplay will shape the future of heart-device procedures, with Minimally Invasive methods leading in preference and Surgical methods adapting to meet emerging demands. ### By Indication: Aortic Stenosis (Largest) vs. Mitral Regurgitation (Fastest-Growing) In the South Korea structural heart-devices market, Aortic Stenosis holds the dominant share, accounting for a significant portion of the segment values. Following closely, Mitral Regurgitation is emerging rapidly, gaining traction among healthcare providers. Meanwhile, Heart Failure and Pulmonary Valve Stenosis are also evident but contribute less to overall market share, illustrating a varied landscape of indicational needs for heart devices. Growth trends for these segments are being shaped by factors such as the aging population and increasing prevalence of heart-related diseases. Aortic Stenosis remains at the forefront due to its high incidence rates. Mitral Regurgitation is witnessing fast growth due to advancements in minimally invasive procedures, while Heart Failure and Pulmonary Valve Stenosis are growing steadily as awareness and treatment options expand in South Korea. Aortic Stenosis (Dominant) vs. Mitral Regurgitation (Emerging) Aortic Stenosis is the dominant indication within the South Korea structural heart-devices market, characterized by its high prevalence and the need for effective treatment solutions. Its market position is strengthened by ongoing technological advancements and effective management strategies. Conversely, Mitral Regurgitation is marked as an emerging segment, benefiting from innovative device development and increasing physician adoption of new therapies. Both indications are critical, but Aortic Stenosis leads due to its clinical demand and established treatment protocols, while Mitral Regurgitation is poised for rapid growth, driven by enhanced awareness and treatment effectiveness. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the South Korea structural heart-devices market, hospitals are the largest end user, accounting for a significant share due to their comprehensive cardiac care services and advanced facilities. Ambulatory surgical centers are gaining traction, driven by the need for cost-effective and efficient surgical procedures that cater to an increasing patient base seeking outpatient care. Cardiology clinics also contribute to the market, albeit on a smaller scale, serving as essential specialized facilities for heart-related treatments and consultations. The growth trends in this segment indicate a shift towards outpatient care, particularly in ambulatory surgical centers, which are becoming the fastest-growing segment. This trend is driven by factors such as technological advancements, increasing patient preference for minimally invasive procedures, and an emphasis on reducing healthcare costs. Hospitals continue to invest in advanced structural heart devices, while cardiology clinics are expanding their service offerings, further enhancing their market presence. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals represent the dominant end user in the South Korea structural heart-devices market, characterized by their ability to provide comprehensive care and access to the latest technologies. They have established infrastructures, skilled personnel, and robust support services that enable them to manage complex cardiac procedures effectively. In contrast, ambulatory surgical centers are emerging rapidly due to their focus on outpatient services, offering a more patient-friendly approach with shorter wait times and lower costs. These centers are increasingly equipped with advanced technologies, enabling them to perform a variety of heart procedures, thus attracting more patients looking for convenience and efficiency. The combination of hospitals' dominance and the rising influence of ambulatory surgical centers signals a dynamic shift in the healthcare landscape. ## Competitive Benchmarking The structural heart-devices market in South Korea is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Key players such as Edwards Lifesciences (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Edwards Lifesciences (US) emphasizes its commitment to research and development, particularly in transcatheter heart valves, while Medtronic (US) leverages its extensive portfolio to integrate digital health solutions into its offerings. Abbott Laboratories (US) is also notable for its aggressive expansion strategy, particularly in the realm of minimally invasive devices, which aligns with the growing demand for less invasive treatment options.The market structure appears moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. This trend is indicative of a broader strategy among key players to adapt to regional market demands while maintaining competitive pricing. The collective influence of these companies shapes a competitive environment where innovation and operational efficiency are paramount. In October Edwards Lifesciences (US) announced the launch of its next-generation transcatheter aortic valve replacement (TAVR) system, which is designed to improve patient outcomes through enhanced delivery mechanisms. This strategic move not only reinforces the company's leadership in the TAVR segment but also reflects its ongoing commitment to advancing minimally invasive cardiac procedures. The introduction of this technology is likely to strengthen Edwards' market position in South Korea, where demand for innovative heart devices is on the rise. In September Medtronic (US) expanded its partnership with a local South Korean healthcare provider to enhance the distribution of its cardiac devices. This collaboration aims to streamline access to advanced heart therapies, thereby addressing the growing needs of the South Korean population. By aligning with local entities, Medtronic is poised to enhance its market penetration and foster trust among healthcare professionals and patients alike. In August Abbott Laboratories (US) unveiled a new digital platform aimed at improving patient engagement and monitoring for those with structural heart conditions. This initiative underscores Abbott's focus on integrating technology into its product offerings, which is increasingly vital in today's healthcare landscape. The platform is expected to facilitate better patient outcomes and adherence to treatment protocols, thereby solidifying Abbott's competitive edge in the market. As of November the competitive trends in the structural heart-devices market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances among companies are becoming more prevalent, as they seek to leverage complementary strengths to enhance innovation and market reach. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to deliver innovative solutions that meet evolving patient needs. ## Recent News & Developments In recent months, the South Korea Structural Heart Devices Market has seen significant advancements, with major players like Medtronic, Abbott Laboratories, and Edwards Lifesciences actively expanding their portfolios to meet growing demand. Medtronic launched its latest transcatheter aortic valve replacement technology in March 2023, aimed at improving surgical outcomes.  Meanwhile, Abbott Laboratories introduced new features in their heart monitoring systems, enhancing patient care. In terms of mergers and acquisitions, Corindus Vascular Robotics completed an acquisition by Siemens Healthineers in September 2022, strengthening their market position.  The growing prevalence of heart diseases in South Korea has spurred investment in innovative solutions, leading to an estimated market valuation growth of 8.5% in the past year alone, contributing to enhanced treatment options for patients. Various companies, including Boston Scientific and CryoLife, have also invested in local Research and Development initiatives to adapt to South Korean healthcare regulations.  The consistent emphasis on quality and regulatory compliance by the South Korean government is paving the way for advanced structural heart devices, thereby influencing market dynamics and encouraging technological collaborations among leading organizations in the sector. ## Report Scope | MARKET SIZE 2024 | 19.25(USD Million) | | --- | --- | | MARKET SIZE 2025 | 20.67(USD Million) | | MARKET SIZE 2035 | 42.15(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.38% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), LivaNova (GB), Cardiac Dimensions (US), AtriCure (US), Terumo Corporation (JP), JenaValve Technology (DE) | | Segments Covered | Type, Procedure Type, Indication, End User | | Key Market Opportunities | Advancements in minimally invasive procedures enhance growth potential in the structural heart-devices market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the structural heart-devices market in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What is the current valuation of the South Korea structural heart-devices market?** A: The market valuation was $19.25 Million in 2024. **Q: What is the projected market size for the South Korea structural heart-devices market by 2035?** A: The projected valuation for 2035 is $42.15 Million. **Q: What is the expected CAGR for the South Korea structural heart-devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 7.38% during the forecast period. **Q: Which companies are the key players in the South Korea structural heart-devices market?** A: Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific. **Q: What are the main segments of the South Korea structural heart-devices market?** A: The main segments include Type, Procedure Type, Indication, and End User. **Q: What was the valuation of Transcatheter Aortic Valve Replacement in 2024?** A: The valuation for Transcatheter Aortic Valve Replacement was $5.0 Million in 2024. **Q: How much is the Mitral Valve Repair Devices segment projected to grow by 2035?** A: The Mitral Valve Repair Devices segment is projected to grow to $9.5 Million by 2035. **Q: What is the expected valuation for Left Atrial Appendage Closure Devices in 2035?** A: The expected valuation for Left Atrial Appendage Closure Devices is $7.0 Million in 2035. **Q: Which end user segment had the highest valuation in 2024?** A: In 2024, the Hospitals segment had the highest valuation at $8.0 Million. **Q: What is the projected valuation for the Ambulatory Surgical Centers segment by 2035?** A: The projected valuation for Ambulatory Surgical Centers is $10.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-structural-heart-devices-market-56901*